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CC BY-NC-ND license (http://creativeBackground/purpose: Erosive oral lichen planus (EOLP) patients with desquamative gingivitis
(DG) are sometimes encountered in our oral mucosal disease clinic. This study assessed hema-
tinic deficiencies and anemia statuses in antigastric parietal cell antibody (GPCA)-positive
EOLP patients with DG (GPCAþ/DGþ/EOLP patients).
Methods: The blood hemoglobin, iron, vitamin B12, folic acid, and homocysteine concentra-
tions and serum GPCA levels in 92 GPCAþ/DGþ/EOLP patients and 184 age- and sex-matched
healthy controls were measured and compared between the two groups.
Results: We found that 27 (29.3%), 16 (17.4%), and 27 (29.3%) of 92 GPCAþ/DGþ/EOLP patients
had hemoglobin (men < 13 g/dL and women < 12 g/dL), iron (< 60 mg/dL), and vitamin B12 (<
200 pg/mL) deficiencies, respectively. Moreover, 37 (40.2%) of 92 GPCAþ/DGþ/EOLP patients
had an abnormally high blood homocysteine level (> 12.1mM). GPCAþ/DGþ/EOLP patients
had a significantly higher frequency of hemoglobin, iron, or vitamin B12 deficiency and an
abnormally high blood homocysteine level than healthy control individuals (all p < 0.001).
Of 27 anemic GPCAþ/DGþ/EOLP patients, 13 (48.2%) had pernicious anemia, five (18.5%) had
iron deficiency anemia, one (3.7%) had thalassemia trait, and the remaining eight (29.6%)
had normocytic anemia. Moreover, of the 92 GPCAþ/DGþ/EOLP patients, 24 had macrocytosis,
and only 13 (54.2%) of these 24 patients had pernicious anemia.
Conclusion: We conclude that GPCAþ/DGþ/EOLP patients may have vitamin B12 deficiency,
iron deficiency, and an abnormally high blood homocysteine level. In addition to pernicioushave no conflicts of interest relevant to this article.
of Dentistry, National Taiwan University Hospital, Number 1, Chang-Te Street, Taipei 10048, Taiwan.
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Desquamative gingivitis (DG) presents mainly as painful
erosions or ulcerations of the attached and free gingivae. It
is now recognized to be a manifestation of several diseases,
principally mucocutaneous autoimmune disorders such as
oral lichen planus (OLP), mucous membrane pemphigoid,
and pemphigus vulgaris.1e3 Our recent study found that 455
(91%), 40 (8%), and five (1%) of 500 DG patients were
associated with erosive oral lichen planus (EOLP),
pemphigus vulgaris, and mucous membrane pemphigoid,
respectively.4
Our previous study found that 84 (26.3%) of 320 OLP
patients were antigastric parietal cell antibody (anti-GPCA)
positive.5 Our recent study also showed a GPCA-positive
rate of 39.6% in 455 EOLP patients with DG (DGþ/EOLP
patients).4 The GPCA may induce destruction of gastric
parietal cells and, in turn, result in failure of intrinsic factor
production.6,7 A lack of intrinsic factor may lead to vitamin
B12 deficiency. Vitamin B12 plays an important role in he-
moglobin (Hb) and DNA synthesis and cell division. Patients
with vitamin B12 deficiency may have Hb deficiency and
macrocytosis [mean corpuscular volume or (MCV)  100 fL]
that finally causes pernicious anemia.8,9 Vitamin B12 defi-
ciency may also be due to an inadequate intake of vitamin
B12-containing foods, vitamin B12 malabsorption, biologic
competition including bacterial overgrowth and tapeworm
infestation, and transcobalamin II deficiency.9 As multiple
causes are involved in vitamin B12 deficiency and macro-
cytosis, it is interesting to know the frequencies of vitamin
B12 deficiency, macrocytosis, and macrocytic anemia in
GPCA-positive DGþ/EOLP patients (GPCAþ/DGþ/EOLP
patients).
Our previous studies demonstrated that some patients
with oral mucosal diseases such as OLP, burning mouth
syndrome, and atrophic glossitis may have autoantibodies
in their sera. Thus, we frequently examined the presence of
different types of autoantibodies such as GPCA, antithyr-
oglobulin antibody (anti-TGA), and antithyroid microsomal
antibody (anti-TMA, also known as antithyroid peroxidase
antibody) in the sera of oral mucosal disease patients,
especially the DGþ/EOLP patients.4,5,10e16 In this study, we
recruited 92 GPCAþ/DGþ/EOLP patients from the oral
mucosal disease clinic of National Taiwan University Hos-
pital (NTUH). For these GPCAþ/DGþ/EOLP patients, com-
plete blood count, serum iron, vitamin B12, folic acid,
homocysteine, TGA, and TMA levels were checked to assess
whether these patients had microcytic, normocytic, or
macrocytic anemia; thalassemia; deficiencies of hema-
tinics; and serum TGA or TMA positivity. These data were
further compared with the corresponding data of 184 age-
and sex-matched healthy control individuals without oralmucosal and systemic diseases to evaluate whether GPCAþ/
DGþ/EOLP patients had higher frequencies of anemia,
vitamin B12 deficiency, macrocytosis (MCV  100 fL),
abnormally high blood homocysteine level, and TGA or TMA
positivity than with healthy control individuals.Materials and methods
Patients
In this study, 92 (14 men and 78 women, age range
29e87 years, mean age 58  12 years) GPCAþ/DGþ/EOLP
patients were enrolled. For each GPCAþ/DGþ/EOLP pa-
tient, two age- (2 years of each patient’s age) and sex-
matched healthy control individuals were selected. Thus,
the normal control group consisted of 184 healthy in-
dividuals (28 men and 156 women, age range 29e87 years,
mean age 57  11 years). All the patients and healthy
control individuals who were seen consecutively, diag-
nosed, and treated in the oral mucosal disease clinic of
NTUH from July 2007 to May 2015 were selected for the
study. DG was diagnosed when patients had painful
erythematous lesions, erosions, or ulcerations on at least
one-quarter of the total maxillary and mandibular
gingivae.1,2 OLP was diagnosed according to the criteria
described previously.5,16 However, all GPCAþ/DGþ/EOLP
patients with areca quid chewing habit, autoimmune dis-
eases (such as systemic lupus erythematosus, rheumatoid
arthritis, Sjogren’s syndrome, pemphigus vulgaris, and
cicatricial pemphigoid), inflammatory diseases, recurrent
aphthous ulcerations, malignancy, or recent surgery were
excluded. In addition, all GPCAþ/DGþ/EOLP patients with
serum creatinine concentrations indicative of renal
dysfunction (men > 131mM, women > 115mM) and those
who reported a history of stroke, heavy alcohol use, or
diseases of the liver, kidney, or coronary arteries were also
excluded.17 Healthy control individuals had dental caries,
pulpal disease, malocclusion, or missing of teeth, but did
not have any oral mucosal or systemic diseases. None of our
GPCAþ/DGþ/EOLP patients had taken any prescription
medication for malignancies, epilepsy, diabetes mellitus,
infection, inflammation, DG, or EOLP at least 3 months
before entering the study.
The blood samples were drawn from all GPCAþ/DGþ/
EOLP patients and healthy control individuals for mea-
surement of complete blood count, blood iron, vitamin B12,
folic acid, and homocysteine concentrations, as well as
serum GPCA, TGA, and TMA levels. All the patients and
healthy control individuals signed the informed consent
forms before entering the study. This study was reviewed
and approved by the Institutional Review Board of NTUH.
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iron, vitamin B12, folic acid, and homocysteine
concentrations
Complete blood count and blood iron, vitamin B12, folic
acid, and homocysteine concentrations were determined
with routine tests performed in the Department of Labo-
ratory Medicine of NTUH as described previously.10e16
Determination of serum anti-GPCA level
The serum GPCA level was detected using the indirect
immunofluorescence technique with rat stomach as a sub-
strate, as described previously.5,10e13 Sera were scored as
positive when they produced fluorescence at a dilution of
10-fold or more.
Determination of serum anti-TGA or anti-TMA level
TGA and TMA titers were measured by a semiquantitative
microtiter particle agglutination test using Serodia-AMC kits
(Fujirebio Inc., Tokyo, Japan), as described previously.5,12
Serum TGA or TMA titers equal to or greater than 1:40
were considered positive.
Statistical analysis
Comparisons of the MCV and the mean blood levels of Hb,
iron, vitamin B12, folic acid, and homocysteine between 92
GPCAþ/DGþ/EOLP patients and 184 age- and sex-matched
healthy control individuals were performed using the Stu-
dent t test. The differences in the frequency of Hb, iron,
vitamin B12, or folic acid deficiency; abnormally high blood
homocysteine level; or serum TGA or TMA positivity be-
tween 92 GPCAþ/DGþ/EOLP patients and 184 age- and sex-
matched healthy control individuals were compared using
the Chi-square test. Comparisons of the MCV; mean bloodTable 1 Mean corpuscular volume and the mean blood concent
homocysteine in 92 antigastric parietal cell antibodyþ/desquama
patients and 184 age- and sex-matched healthy control individua
GPCAþ/DGþ/EOLP patients
(n Z 92)
Mean  SD Range
Hb (g/dL)
Men 14.4  1.3 (n Z 14) 12.7e16.0
Women 12.6  1.2 (n Z 78) 8.9e15.2
MCV (fL) 92.3  8.9 66.7e117.2
Iron (mg/dL)
Men 108.6  37.0 (n Z 14) 50.0e196.0
Women 82.8  34.0 (n Z 78) 25.0e210.0
Vitamin B12 (pg/mL) 529.4  318.3 150.0e1000.0
Folic acid (ng/mL) 15.0  5.9 5.7e24.0
Homocysteine (mM) 10.7  5.4 3.1e41.5
SD Z standard deviation.
a Comparisons of mean corpuscular volume, blood concentrations
between 92 antigastric parietal cell antibodyþ/desquamative gingiv
matched healthy controls by Student t test, with p < 0.05.concentrations of Hb, iron, vitamin B12, folic acid, and
homocysteine; and serum TGA or TMA positivity between
any two of the three groups of patients with macrocytic,
normocytic, or microcytic red blood cells (RBCs) were
performed using Student t test or Chi-square test where
appropriate. The result was considered to be significant
when p < 0.05.Results
The MCV and mean blood concentrations of Hb, iron,
vitamin B12, folic acid, and homocysteine in 92 GPCAþ/
DGþ/EOLP patients and 184 age- and sex-matched healthy
control individuals are shown in Table 1. As men usually
have higher blood levels of Hb and iron than women, these
two mean levels were calculated separately for men and
women. We found significantly lower mean Hb (for both
men and women; p < 0.001 for both), iron (for women only;
p < 0.001), and vitamin B12 (p < 0.001) levels as, well as a
significantly higher mean blood homocysteine level
(p < 0.001) in GPCAþ/DGþ/EOLP patients than in healthy
control individuals (Table 1).
According to the World Health Organization (WHO)
criteria, men with Hb < 13 g/dL and women with Hb < 12 g/
dL were defined as having Hb deficiency or anemia.18,19
Furthermore, patients with a serum iron level of < 60 mg/
dL,20 a vitamin B12 level of < 200 pg/mL,17 or a folic acid
level of < 4 ng/mL21 were defined as having iron, vitamin
B12, or folic acid deficiency, respectively. Moreover, pa-
tients with a blood homocysteine level of > 12.1mM (which
was the mean blood homocysteine level of healthy control
individuals plus two standard deviations) were defined as
having an abnormally high homocysteine level. According to
the abovementioned definitions, 27 (29.3%), 16 (17.4%), 27
(29.3%), and 0 (0%) of 92 GPCAþ/DGþ/EOLP patients had
Hb, iron, vitamin B12, and folic acid deficiencies, respec-
tively. Moreover, 37 (40.2%), 26 (28.3%), and 35 (38.0%) ofrations of hemoglobin (Hb), iron, vitamin B12, folic acid, and
tive gingivitisþ/erosive oral lichen planus (GPCAþ/DGþ/EOLP)
ls.
Healthy controls
(n Z 184)
p
(Student t test)
Mean  SD Range
15.4  0.5 (n Z 28) 14.3e16.4 <0.001a
13.6  0.7 (n Z 156) 12.2e15.4 <0.001a
91.2  3.4 80.5e98.6 0.141
103.2  26.0 (n Z 28) 63.0e153.0 0.586
101.3  27.3 (n Z 156) 60.0e204.0 <0.001a
708.1  225.8 267.0e1000.0 <0.001a
15.0  6.2 4.1e24.0 >0.99
8.3  1.9 4.3e13.5 <0.001a
of hemoglobin, iron, vitamin B12, folic acid, and homocysteine
itisþ/erosive oral lichen planus patients and 184 age- and sex-
Table 2 Number and percentage of individuals with hemoglobin (Hb), iron, vitamin B12, or folic acid deficiency; abnormally
high blood homocysteine level; or antithyroglobulin antibody (TGA) or antithyroid microsomal antibody (TMA) positivity in 92
antigastric parietal cell antibodyþ/desquamative gingivitisþ/erosive oral lichen planus (GPCAþ/DGþ/EOLP) patients and 184
age- and sex-matched healthy control individuals.
Factor GPCAþ/DGþ/EOLP patients
(n Z 92)
Healthy controls
(n Z 184)
p
Hb deficiency (men < 13 g/dL, women < 12 g/dL) 27 (29.3%) 0 (0%) <0.001a
Iron deficiency (< 60 mg/dL) 16 (17.4%) 0 (0%) <0.001a
Vitamin B12 deficiency (< 200 pg/mL) 27 (29.3%) 0 (0%) <0.001a
Folic acid deficiency (< 4 ng/mL) 0 (0%) 0 (0%) ND
High homocysteine levelb (> 12.1mM) 37 (40.2%) 8 (4.3%) <0.001a
TGA positivity 26 (28.3%) 3 (1.6%) <0.001a
TMA positivity 35 (38.0%) 3 (1.6%) <0.001a
DG Z desquamative gingivitis; ND Z not done.
a Comparison of frequency of hemoglobin, iron, vitamin B12, or folic acid deficiency; abnormally high blood homocysteine level; or
antithyroglobulin antibody or antithyroid microsomal antibody positivity between 92 antigastric parietal cell antibodyþ/desquamative
gingivitisþ/erosive oral lichen planus patients and 184 age- and sex-matched healthy control individuals by Chi-square test, with
p < 0.05.
b A homocysteine level was defined to be high when the homocysteine level of patients was greater than the mean serum homo-
cysteine level of healthy control individuals plus two standard deviations.
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blood homocysteine level (> 12.1mM), serum TGA positivity,
and serum TMA positivity, respectively (Table 2). However,
none of the normal control individuals was diagnosed as
having Hb, iron, vitamin B12, and folic acid deficiencies
according to the aforementioned strict WHO criteria.
However, a high blood homocysteine level (> 12.1mM),
serum TGA positivity, and serum TMA positivity were found
in eight (4.3%), three (1.6%), and three (1.6%) normal
control individuals, respectively. GPCAþ/DGþ/EOLP pa-
tients had a significantly higher frequency of Hb, iron, or
vitamin B12 deficiency; abnormally high blood homocyste-
ine level; and serum TGA or TMA positivity than healthy
control individuals (all p < 0.001; Table 2).
In this study, 27 (29.3%) GPCAþ/DGþ/EOLP patients were
diagnosed as having anemia according to the WHO
criteria.18 Considering the diagnostic criteria for pernicious
anemia as having MCV  100 fL, vitamin B12 < 200 pg/mL,
and serum GPCA positivity;13 iron deficiency anemia as
having MCV < 80 fL and iron < 60 mg/dL;19,20 and thalas-
semia trait as having MCV < 74 fL, RBC count > 5.0  1012/
L, and Mentzer index (MCV/RBC) < 13,22 we found that of
27 anemic GPCAþ/DGþ/EOLP patients, 13 had pernicious
anemia, five had iron deficiency anemia, one had thalas-
semia trait, and the remaining eight had normocytic ane-
mia (Table 3).Table 3 Anemia types of 27 antigastric parietal cell antibodyþ/
Anemia type
Patient no. (%) MCV (f
Pernicious anemia 13 (48.2) 100
Normocytic anemia 8 (29.6) 80e99
Iron deficiency anemia 5 (18.5) <80
Thalassemia trait 1 (3.7) <74
Total 27 (100.0)
MCV Z mean corpuscular volume.When 92 GPCAþ/DGþ/EOLP patients were further divided
into three groups, Group 1 (24 patients with MCV  100 fL),
Group 2 (61 patients with MCV between 80 fL and 99.9 fL),
andGroup 3 (seven patients withMCV< 80 fL), we found that
Group 1 patients had significantly higher MCV (p < 0.001), a
lower mean Hb level (for both men and women; men,
p Z 0.001; women, p Z 0.003), a lower mean serum iron
level (for men only; pZ 0.012), a lower mean serum vitamin
B12 level (p < 0.001), and a higher mean serum homocyste-
ine level (p < 0.001) than Group 2 patients (Table 4). More-
over, Group 3 patients had a significantly lower mean Hb
level (for women only; p < 0.001), lower MCV (p < 0.001), a
lower mean serum iron level (for women only; p Z 0.003),
and a lowermean vitamin B12 level (pZ 0.035) than Group 2
patients (Table 4). In addition, Group 1 patients had signifi-
cantly higher MCV (p < 0.001), a higher mean Hb level (for
women only; pZ 0.029), a higher mean serum iron level (for
women only; p Z 0.001), and a lower mean serum vitamin
B12 level (p < 0.001) than Group 3 patients (Table 4).Discussion
This study found that of the 92 GPCAþ/DGþ/EOLP patients,
24 produced macrocytic RBCs, 61 normocytic RBCs, and
seven microcytic RBCs. Moreover, 27 (29.3%) of the 92desquamative gingivitisþ/erosive oral lichen planus patients.
Patient no. (%)
L) Vitamin B12 deficiency
(< 200 pg/mL)
Iron deficiency
(< 60 mg/dL)
13 (100.0) 3 (23.1)
.9 0 (0.0) 3 (37.5)
3 (60.0) 5 (100.0)
0 (0.0) 0 (0.0)
16 (59.3) 11 (40.7)
Table 4 Mean corpuscular volume (MCV); mean blood concentrations of hemoglobin (Hb), iron, vitamin B12, folic acid, and
homocysteine; and antithyroglobulin antibody (TGA) or antithyroid microsomal antibody (TMA) positivity in 92 antigastric pa-
rietal cell antibodyþ/desquamative gingivitisþ/erosive oral lichen planus (GPCAþ/DGþ/EOLP) patients, including 24 with MCV
100 fL (Group 1), 61 with MCV between 80 fL and 99.9 fL (Group 2), and seven with MCV < 80 fL (Group 3).
GPCA-positive EOLP patients with DG (n Z 92)
Group 1
MCV  100 fL
(n Z 24)
pa
(Group 1 vs.
Group 2)
Group 2
MCV 80e99.9 fL
(n Z 61)
pa
(Group 2 vs.
Group 3)
Group 3
MCV < 80 fL
(n Z 7)
pa
(Group 1 vs.
Group 3)
Mean  SD Mean  SD Mean  SD
Hb (g/dL)
Men 12.8  0.1
(n Z 4)
0.001a 15.0  1.0
(n Z 10)
ND (n Z 0) ND
Women 12.2  1.2
(n Z 20)
0.003a 13.0  0.9
(n Z 51)
<0.001a 11.0  1.1
(n Z 7)
0.029a
MCV (fL) 103.5  3.5 <0.001a 90.1  3.9 <0.001a 73.1  4.8 <0.001a
Iron (mg/dL)
Men 72.0  14.9
(n Z 4)
0.012a 123.2  32.8
(n Z 10)
ND (n Z 0) ND
Women 82.2  21.7
(n Z 20)
0.417 89.1  35.2
(n Z 51)
0.003a 45.4  26.9
(n Z 7)
0.001a
Vitamin B12
(pg/mL)
172.5  19.5 <0.001a 679.0  262.8 0.035a 448.7  316.1 <0.001a
Folic acid
(ng/mL)
12.2  6.1 0.109 14.5  5.8 0.865 14.9  6.5 0.318
Homocysteine
(mM)
15.9  6.7 <0.001a 8.6  3.2 0.076 10.9  3.2 0.068
TGA positivity 7 (29.2%) 0.997 16 (26.2%) 0.628 3 (42.9%) 0.824
TMA positivity 9 (37.5%) 0.988 21 (34.4%) 0.134 5 (71.4%) 0.248
ND Z not done; SD Z standard deviation.
a Comparisons of mean corpuscular volume; mean blood concentrations of hemoglobin, iron, vitamin B12, folic acid, and homocys-
teine; and serum thyroglobulin antibody or thyroid microsomal antibody positivity between Groups 1 and 2, between Groups 2 and 3, and
between Groups 1 and 3 by Student t test or Chi-square test, where appropriate.
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anemic GPCAþ/DGþ/EOLP patients, 13 had macrocytic
anemia (MCV  100 fL; all had pernicious anemia including
three having concomitant iron deficiency),13,14 six had
microcytic anemia (MCV < 80 fL; five had iron deficiency
anemia and one had thalassemia trait),19,22 and eight had
normocytic anemia (MCV between 80 fL and 99.9 fL;
including three having concomitant iron deficiency). As
GPCA may induce destruction of gastric parietal cells and
further result in failure of intrinsic factor production,
GPCAþ/DGþ/EOLP patients are supposed to have vitamin
B12 deficiency, which in turn results in the generation of
macrocytic RBCs and pernicious anemia.13,14 However, we
showed that only 27 (29.3%), 24 (26.1%), and 13 (14.1%) of
92 GPCAþ/DGþ/EOLP patients had vitamin B12 deficiency,
macrocytosis, and pernicious anemia, respectively. We also
found that 13 (48.1%) of our 27 vitamin B12 deficiency pa-
tients and 13 (54.2%) of our 24 macrocytosis patients had
pernicious anemia. Our previous studies demonstrated that
16 (12.9%) of 124 GPCA-positive patients, 17 (18.9%) of 90
vitamin B12-deficient patients, and 10 (16.7%) of 60
macrocytosis patients with oral mucosal diseases (including
atrophic glossitis, burning mouth syndrome, OLP, and
recurrent aphthous ulcerations) had pernicious
anemia.13e15 Statistical analyses of the aforementioned
data indicate that GPCAþ/DGþ/EOLP patients with vitaminB12 deficiency or macrocytosis had a significantly high
frequency to contract pernicious anemia than oral mucosal
disease patients with vitamin B12 deficiency (pZ 0.005) or
macrocytosis (p Z 0.001), respectively.
This study found microcytosis in seven GPCAþ/DGþ/
EOLP patients. Of these seven microcytosis patients, five
had iron deficiency anemia including three having
concomitant vitamin B12 deficiency and an abnormally high
serum homocysteine level, one had thalassemia trait, and
the remaining one had normal Hb, vitamin B12, folic acid,
and iron levels. The five anemic microcytosis patients had
severe iron deficiency (serum iron level < 35 mg/dL). The
severe iron deficiency may play an important role in the
generation of microcytic RBCs in these five anemic micro-
cytosis patients. In addition, vitamin B12 deficiency may be
the predominant factor that results in an abnormally high
serum homocysteine level in patients,14 and both iron and
vitamin B12 deficiencies may be the factors causing anemia
in these five anemic microcytosis patients.14,19
In the present study, 61 of 92 GPCAþ/DGþ/EOLP patients
had normocytosis. Of these 61 normocytosis patients, eight
had normocytic anemia with three having concomitant iron
deficiency, seven had iron deficiency (six with serum iron
levels between 48 mg/dL and 59 mg/dL; one with a serum
iron level of 33 mg/dL), and none had vitamin B12 and folic
acid deficiencies. The normal vitamin B12 and folic acid
Anemia in desquamative gingivitis patients 865levels and only a small percentage (11.5%) of our patients
with mild iron deficiency may be the major factors resulting
in normocytosis in our patients. GPCAþ/DGþ/EOLP patients
may tend to have intrinsic factor deficiency that results in
malabsorption of vitamin B12 from the terminal ileum and
finally in vitamin B12 deficiency.13e15 Therefore, it is
interesting to know why our GPCAþ/DGþ/EOLP patients do
not have vitamin B12 deficiency. It has been reported that
supplementation with oral vitamin B12 is a safe and
effective treatment for the vitamin B12 deficiency state.
Even when intrinsic factor is not present to aid the ab-
sorption of vitamin B12 or in other diseases that affect the
usual absorption sites in the terminal ileum, oral therapy
with vitamin B12 remains effective.9 Therefore, although
GPCAþ/DGþ/EOLP patients have GPCA in their sera, enough
dietary supply of vitamin B12 may prevent the occurrence
of vitamin B12 deficiency in these patients. In addition,
those GPCA-positive patients require a sufficiently long
period of time to develop autoimmune gastritis, which
finally results in complete failure of intrinsic factor pro-
duction.8,23 Therefore, the residual gastric parietal cells of
patients with lower serum titer of GPCA, or those with
medium or higher serum titer of GPCA of a shorter duration
may still have some ability to produce intrinsic factors that
help absorb vitamin B12 from the small intestine.
Carrozzo et al24 discovered the presence of serum
GPCA in three (6%) and antithyroid antibodies in five (10%)
of 50 OLP patients. Our previous study demonstrated that
84 (26.3%), 68 (21.3%), and 78 (24.4%) of 320 OLP patients
had GPCA, TGA, and TMA positivities, respectively.5
Moreover, 34 (40.5%) of 84 GPCA-positive OLP patients
also had serum TGA/TMA positivity and 34 (35.1%) of 97
TGA/TMA-positive OLP patients had concomitant GPCA
positivity.5 Our recent study found a GPCA, TGA, or TMA
positive rate of 39.6% (180 patients), 46.4% (211 patients),
or 45.1% (205 patients) in 455 DGþ/EOLP patients.4
Furthermore, 108 (60.0%) of 180 GPCAþ/DGþ/EOLP pa-
tients also had serum TGA/TMA positivity and 108 (38.7%)
of 279 TGA/TMA-positive DGþ/EOLP patients had
concomitant GPCA positivity.4 This study showed a TGA or
TMA positive rate of 28.3% or 38.0%, respectively, in 92
GPCAþ/DGþ/EOLP patients. These findings suggest a high
frequency of possessing both antigastric and antithyroid
autoantibodies in EOLP and DGþ/EOLP patients. In addi-
tion, the high GPCA, TGA, and TMA positive rates in EOLP
and DGþ/EOLP patients indicate an intimate association
of EOLP and DGþ/EOLP patients with autoimmune gastric
and thyroid diseases.4,5,24 Further studies are necessary to
confirm this intimate association.
Homocysteine is a sulfur-containing amino acid that is
formed during methionine metabolism.25 Both vitamin B12
and folic acid act as coenzymes for the conversion of ho-
mocysteine to methionine.26 Higher blood homocysteine
levels can cause oxidative stress, damage endothelium, and
enhance thrombogenicity in experimental studies, and thus
are associated with increased rates of coronary heart dis-
ease and stroke.25,27e30 Moreover, measurement of both
serum methylmalonic acid and homocysteine levels has
been discovered to be a more sensitive method of screening
for vitamin B12 deficiency, with the sensitivity being 99.8%,
and thus can be used for detecting subclinical vitamin B12
deficiency.9,31 In this study, an abnormally higher bloodhomocysteine level was detected in 37 (40.2%) of the 92
GPCAþ/DGþ/EOLP patients, but could be found in only
eight (4.3%) of the 184 healthy control individuals. Previous
studies demonstrated that the high blood homocysteine
level found in patients is due to deficiencies in folic acid,
vitamin B12, and vitamin B6, because a supplement therapy
with folic acid, vitamin B12, and vitamin B6 can reduce
their blood homocysteine levels.28,32,33 In this study, of 37
patients with abnormally higher blood homocysteine levels,
24 (64.9%) had vitamin B12 deficiency according to the WHO
definition (vitamin B12 level < 200 pg/mL)17 and 32 (86.5%)
had relative vitamin B12 deficiency according to our pre-
vious definition (vitamin B12 level  450 pg/mL).32,33
Furthermore, of our 37 patients with abnormally higher
blood homocysteine levels, none had folic acid deficiency
according to the WHO definition (folic acid level < 4 ng/
mL)21 and only five (13.5%) had relative folic acid deficiency
according to our previous definition (folic acid level  6 ng/
mL).32,33 Moreover, our 92 GPCAþ/DGþ/EOLP patients also
had a significantly lower mean serum vitamin B12 level than
healthy control individuals. Therefore, the high blood ho-
mocysteine level in our 92 GPCAþ/DGþ/EOLP patients may
predominantly be due to vitamin B12 deficiency rather than
folic acid deficiency.
Our results demonstrated that, according to WHO defi-
nitions, 27 (29.3%), 16 (17.4%), and 27 (29.3%) of 92 GPCAþ/
DGþ/EOLP patients had Hb, iron, and vitamin B12 de-
ficiencies, respectively. Moreover, 37 (40.2%), 26 (28.3%),
and 35 (38.0%) of our 92 GPCAþ/DGþ/EOLP patients had an
abnormally high blood homocysteine level, serum TGA
positivity, and serum TMA positivity, respectively. GPCAþ/
DGþ/EOLP patients had a significantly higher frequency of
Hb, iron, or vitamin B12 deficiency; abnormally high blood
homocysteine level; and serum TGA or TMA positivity than
healthy control individuals. Of 27 anemic GPCAþ/DGþ/
EOLP patients, 13 had pernicious anemia, five had iron
deficiency anemia, one had thalassemia trait, and the
remaining eight had normocytic anemia. Moreover, of the
92 GPCAþ/DGþ/EOLP patients, 24 had macrocytosis, and
only 13 of these 24 macrocytosis patients had pernicious
anemia. We conclude that GPCAþ/DGþ/EOLP patients have
a significantly higher frequency of iron and vitamin B12
deficiencies, abnormally high blood homocysteine level,
and serum TGA or TMA positivity than healthy control in-
dividuals. In addition to pernicious anemia (14.1%), GPCAþ/
DGþ/EOLP patients may have normocytic anemia (8.7%) or
microcytic anemia (6.5%).
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